Abstract
Madariaga virus (MADV) and Venezuelan equine encephawere detected in Panama during 1961‒2023. We delitis virus (VEEV) are emerging arboviruses affecting rural scribed the clinical signs and symptoms and epidemiologic and remote areas of Latin America. However, clinical and characteristics of those cases, and also explored signs and epidemiologic reports are limited, and outbreaks are occur-symptoms as potential predictors of encephalitic alphavirus ring at an increasing frequency. We addressed the data gap infection compared with those of other arbovirus infections by analyzing all available clinical and epidemiologic data of occurring in the region. Our results highlight the challenges MADV and VEEV infections recorded since 1961 in Pan-for the clinical diagnosis of alphavirus disease in endemic ama. A total of 168 human alphavirus encephalitis cases regions with overlapping circulation of multiple arboviruses.
| Original language | English |
|---|---|
| Pages (from-to) | S94-S104 |
| Journal | Emerging Infectious Diseases |
| Volume | 30 |
| Issue number | 14 |
| DOIs | |
| State | Published - Nov 2024 |
Bibliographical note
Publisher Copyright:© 2024 Centers for Disease Control and Prevention (CDC). All rights reserved.
Funding
We thank Betsy Dutary, Julio Cisneros, Evelia Quiroz, and Mariana Garcia, who worked to develop laboratory dengue surveillance system and alphavirus surveillance. We thank Kathryn Hanley for support with study design and funding. This study was partially supported by the Armed Forces Health Surveillance Division, Global Emerging Infections Surveillance Branch, ProMIS ID no. P0052_23_NM awarded to D.R.S. J.P.C. is funded by the Clarendon Scholarship from the University of Oxford (grant no. SFF1920_CB2_MPLS_1293647). This work was supported by SENACYT (grant no. FID-2021-96 to J.P.C.); the National Institute of Allergy and Infectious Diseases, the National Institutes of Health (grant no. K08AI110528 to J.J.W.), the Centers for Research in Emerging Infectious Diseases Coordinating Research on Emerging Arboviral Threats Encompassing the NEOtropics (CREATE-NEO) (grant no. 1U01AI151807 awarded to N.V. and K.A.H.), and by the National Institutes of Health and the World Reference Center for Emerging Viruses and Arboviruses (NIH R24 AI120942 to S.C.W.). C.A.D. was supported by the NIHR HPRU in Emerging and Zoonotic Infections, a partnership between Public Health England, the University of Oxford, the University of Liverpool, and the Liverpool School of Tropical Medicine (grant no. NIHR200907). W.M.S. is supported by the Global Virus Network fellowship and the National Institutes of Health (grant no. AI12094) Global Virus Network fellowship, Burroughs Wellcome fund (no. 1022448), and Wellcome Trust-Digital Technology Development award, Climate Sensitive Infectious Disease Modelling (no. 226075/ Z/22Z). M.L.N. is a CNPq Research Fellow supported by a Fundação de Amparo à Pesquisa do Estado de São Paulo grant (no.22/03645-1). B.P.D. is a CNPq Research Fellow. N.R.F. acknowledges support from the Bill and Melinda Gates Foundation (no. INV034540), and Medical Research Council—Sao Paulo Research Foundation CADDE partnership award (no. MR/S0195/ 1 and FAPESP no. 18/14389-0). A.Y.V. acknowledges Research Command funding (contract no. NCRADANMRC-20-10993). This study was partially supported by the Armed Forces Health Surveillance Division, Global Emerging Infections Surveillance Branch, ProMIS ID no. P0052_23_NM awarded to D.R.S. J.P.C. is funded by the Clarendon Scholarship from the University of Oxford (grant no. SFF1920_CB2_MPLS_1293647). This work was supported by SENACYT (grant no. FID-2021-96 to J.P.C.); the National Institute of Allergy and Infectious Diseases, the National Institutes of Health (grant no. K08AI110528 to J.J.W.), the Centers for Research in Emerging Infectious Diseases Coordinating Research on Emerging Arboviral Threats Encompassing the NEOtropics (CREATE-NEO) (grant no. 1U01AI151807 awarded to N.V. and K.A.H.), and by the National Institutes of Health and the World Reference Center for Emerging Viruses and Arboviruses (NIH R24 AI120942 to S.C.W.). C.A.D. was supported by the NIHR HPRU in Emerging and Zoonotic Infections, a partnership between Public Health England, the University of Oxford, the University of Liverpool, and the Liverpool School of Tropical Medicine (grant no. NIHR200907). W.M.S. is supported by the Global Virus Network fellowship and the National Institutes of Health (grant no. AI12094) Global Virus Network fellowship, Burroughs Wellcome fund (no. 1022448), and Wellcome Trust-Digital Technology Development award, Climate Sensitive Infectious Disease Modelling (no. 226075/ Z/22Z). M.L.N. is a CNPq Research Fellow supported by a Fundação de Amparo à Pesquisa do Estado de São Paulo grant (no.22/03645-1). B.P.D. is a CNPq Research Fellow. N.R.F. acknowledges support from the Bill and Melinda Gates Foundation (no. INV034540), and Medical Research Council—Sao Paulo Research Foundation CADDE partnership award (no. MR/S0195/ 1 and FAPESP no. 18/14389-0). A.Y.V. acknowledges Research Command funding (contract no. NCRADA-NMRC-20-10993).
| Funders | Funder number |
|---|---|
| Conselho Nacional de Desenvolvimento Científico e Tecnológico | |
| Wellcome Trust-Digital | |
| National Institute for Health Research Health Protection Research Unit | |
| National Institute of Allergy and Infectious F32-AI286447 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R01AI168214 Jason W. Rosch Diseases National Institute of Allergy and Infectious P30 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R00-AI166116 Christopher D. Radka Diseases National Institute of Allergy and Infectious T32-AI106700 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R01AI192221 Jason W. Rosch Diseases National Inst... | |
| Centers for Research in Emerging Infectious Diseases | |
| Jiatong–Liverpool University | |
| Liverpool School of Tropical Medicine | AI12094, NIHR200907 |
| National Institutes of Health (NIH) | K08AI110528, R24 AI120942 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | 18/14389-0, 22/03645-1, MR/S0195/ 1, NCRADA-NMRC-20-10993 |
| CREATE-NEO | 1U01AI151807 |
| Bill and Melinda Gates Foundation | INV034540 |
| UK Medical Research Council, Engineering and Physical Sciences Research Council | MR/X020258/1 |
| Climate Sensitive Infectious Disease Modelling | 226075/ Z/22Z |
| Armed Forces Health Surveillance Division | P0052_23_NM |
| Oxford Martin School, University of Oxford | SFF1920_CB2_MPLS_1293647 |
| Burroughs Wellcome Fund | 1022448 |
| Secretaría Nacional de Ciencia, Tecnología e Innovación | FID-2021-96 |
ASJC Scopus subject areas
- Epidemiology
- Microbiology (medical)
- Infectious Diseases